Cargando…

Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages

Detalles Bibliográficos
Autores principales: Zhang, Jiawen, Jiang, Peiyu, Sheng, Lei, Liu, Yunyi, Liu, Yixuan, Li, Min, Tao, Meng, Hu, Liang, Wang, Xiaoyan, Yang, Yanjing, Xu, Yang, Liu, Wentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964351/
https://www.ncbi.nlm.nih.gov/pubmed/35371112
http://dx.doi.org/10.3389/fimmu.2022.881277
_version_ 1784678196719910912
author Zhang, Jiawen
Jiang, Peiyu
Sheng, Lei
Liu, Yunyi
Liu, Yixuan
Li, Min
Tao, Meng
Hu, Liang
Wang, Xiaoyan
Yang, Yanjing
Xu, Yang
Liu, Wentao
author_facet Zhang, Jiawen
Jiang, Peiyu
Sheng, Lei
Liu, Yunyi
Liu, Yixuan
Li, Min
Tao, Meng
Hu, Liang
Wang, Xiaoyan
Yang, Yanjing
Xu, Yang
Liu, Wentao
author_sort Zhang, Jiawen
collection PubMed
description
format Online
Article
Text
id pubmed-8964351
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89643512022-03-31 Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages Zhang, Jiawen Jiang, Peiyu Sheng, Lei Liu, Yunyi Liu, Yixuan Li, Min Tao, Meng Hu, Liang Wang, Xiaoyan Yang, Yanjing Xu, Yang Liu, Wentao Front Immunol Immunology Frontiers Media S.A. 2022-03-14 /pmc/articles/PMC8964351/ /pubmed/35371112 http://dx.doi.org/10.3389/fimmu.2022.881277 Text en Copyright © 2022 Zhang, Jiang, Sheng, Liu, Liu, Li, Tao, Hu, Wang, Yang, Xu and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zhang, Jiawen
Jiang, Peiyu
Sheng, Lei
Liu, Yunyi
Liu, Yixuan
Li, Min
Tao, Meng
Hu, Liang
Wang, Xiaoyan
Yang, Yanjing
Xu, Yang
Liu, Wentao
Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
title Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
title_full Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
title_fullStr Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
title_full_unstemmed Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
title_short Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
title_sort corrigendum: a novel mechanism of carvedilol efficacy for rosacea treatment: toll-like receptor 2 inhibition in macrophages
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964351/
https://www.ncbi.nlm.nih.gov/pubmed/35371112
http://dx.doi.org/10.3389/fimmu.2022.881277
work_keys_str_mv AT zhangjiawen corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT jiangpeiyu corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT shenglei corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT liuyunyi corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT liuyixuan corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT limin corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT taomeng corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT huliang corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT wangxiaoyan corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT yangyanjing corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT xuyang corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages
AT liuwentao corrigendumanovelmechanismofcarvedilolefficacyforrosaceatreatmenttolllikereceptor2inhibitioninmacrophages